Company Profile

Alvotech Stock Price, News & Analysis

Ticker:
ALVO
Exchange:
NASDAQ
Sector:
Biotechnology
Location:
Headquartered in the United States and listed on NASDAQ, Alvotech is followed within the biotech universe for its exposure to catalyst-driven execution.

Stock performance

3.70 USD (+1.37%)

Close

Last updated: June 23, 2026 at 00:00

1.25B USD

Market cap

Why the stock is moving

ALVO is trading with a steady catalyst profile while investors wait for the next headline that changes the story.

Company overview

Business overview

Alvotech is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NASDAQ, Alvotech is followed within the biotech universe for its exposure to catalyst-driven execution.

Business Model Characteristics

Alvotech follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.

Position Within the Biotechnology Landscape

Compared with more mature healthcare peers, Alvotech sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.

Future catalysts

Recent news

The five most recent feed items are shown below in reverse chronological order.

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of Alvotech (ALVO)?

    Alvotech (ALVO) most recently closed at 3.70 USD, a +1.37% move versus the previous session.

    What is the market cap of Alvotech (ALVO)?

    Alvotech currently has a market capitalization of 1.25B USD on BioPharmSignal.

    What does Alvotech do?

    Alvotech is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

    On which exchange is ALVO stock listed?

    Alvotech (ALVO) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Alvotech is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.

    What is Alvotech?

    Alvotech is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.

    Which conditions is Alvotech targeting with Alvotech?

    Alvotech is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

    What is Investors?

    Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.